Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:
• an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.
• fulvestrant in women with disease progression following endocrine therapy.
Product Name : Palbonix
Generic Name : Palbociclib
Formulation : Capsules
Available Pack Size : 21’s Pot
Available Strengths : 125mg
Categories : Anti-viral, Biotech Products, Drugs to treat Hepatitis
Manufacturer : Beacon Pharmaceuticals Ltd.